Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SET pseudogene 20 (SETP20) is designated as a pseudogene, a nonfunctional DNA segment that resembles functional genes but carries mutations or deletions preventing protein expression [9][5][3]. Pseudogenes can sometimes regulate gene expression at the RNA level, acting as decoys for miRNAs or indirectly modulating their parent gene, but no direct biological or therapeutic role has been described for SETP20 specifically [9][1]. There is no evidence SETP20 encodes a protein or serves as a drug target, biomarker, or disease-associated gene. No aliases or alternative names are established, and there is little evidence for any functional or disease relevance [5][9][3]. If you require structured biomedical target annotation, SETP20 should be flagged as a non-target or uncharacterized/incorrect entry due to its classification as a pseudogene and lack of functional or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SET pseudogene 20 (SETP20).